ADVFN Logo
Registration Strip Icon for discussion Register to chat with like-minded investors on our interactive forums.
TransCode Therapeutics Inc

TransCode Therapeutics Inc (RNAZ)

0.80
-0.029
(-3.50%)
Closed July 23 4:00PM
0.45
-0.3425
(-43.22%)
After Hours: 7:59PM

Income Statement

Balance Sheet

Cash Flow

Quarter End Jun 2022Sep 2022Dec 2022Mar 2023Jun 2023Sep 2023Dec 2023Mar 2024
USD ($)USD ($)USD ($)USD ($)USD ($)
Total Revenue 00000000
Operating Income -4.71M-4.95M-5.53M-4.9M-5.13M-5.33M-4.06M-3.29M
Pre Tax Income -4.67M-4.29M-5.13M-4.82M-4.34M-5.3M-4.09M-3.33M
Net Income -4.67M-4.29M-5.13M-4.82M-4.34M-5.3M-4.09M-3.33M
Preferred Dividends 00000000
Basic Earnings Per Share (EPS) 00000000
EBIT -4.67M-4.3M-5.14M-4.82M-4.34M-5.3M-4.03M-3.26M
EBITDA -4.69M-4.93M-5.5M-4.87M-5.1M-5.3M-4.03M-3.26M
Year End December 30 2023 20192020202120222023
USD ($)USD ($)USD ($)USD ($)USD ($)
Total Revenue 00000
Operating Income -457k-726k-6.15M-18.67M-19.42M
Pre Tax Income -607k-2.34M-6.84M-17.57M-18.55M
Net Income -607k-2.34M-6.84M-17.57M-18.55M
Preferred Dividends 00000
Basic Earnings Per Share (EPS) -0.079-0.307-0.53-1.354-0.923
EBIT -457k-726k-5.88M-17.59M-18.5M
EBITDA -457k-726k-6.11M-18.57M-19.3M